| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,981 |
14,460 |
$1.18M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,333 |
9,084 |
$486K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,249 |
1,166 |
$76K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,002 |
998 |
$71K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
775 |
766 |
$54K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,003 |
941 |
$48K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,680 |
1,629 |
$41K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,650 |
2,471 |
$26K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,099 |
1,989 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,925 |
1,852 |
$19K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
803 |
795 |
$14K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
857 |
845 |
$12K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
147 |
145 |
$12K |
| 99051 |
|
623 |
613 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
1,936 |
1,896 |
$6K |
| A7037 |
Tubing used with positive airway pressure device |
1,690 |
1,588 |
$6K |
| 99173 |
|
2,152 |
2,108 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
29 |
29 |
$3K |
| 96160 |
|
269 |
259 |
$3K |
| 81000 |
|
2,159 |
2,067 |
$3K |
| 85014 |
|
1,189 |
1,172 |
$2K |
| 81002 |
|
901 |
861 |
$2K |
| A7016 |
Dome and mouthpiece, used with small volume ultrasonic nebulizer |
1,671 |
1,573 |
$2K |
| 86308 |
|
370 |
360 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
161 |
145 |
$1K |
| 90473 |
|
119 |
118 |
$1K |
| 87807 |
|
74 |
71 |
$956.30 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14 |
14 |
$70.00 |
| 94760 |
|
1,173 |
1,090 |
$19.35 |
| 94664 |
|
52 |
52 |
$11.19 |
| 90633 |
|
83 |
81 |
$0.00 |
| 90670 |
|
349 |
348 |
$0.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
51 |
51 |
$0.00 |
| 90710 |
|
13 |
13 |
$0.00 |
| 90734 |
|
30 |
29 |
$0.00 |
| 90715 |
|
27 |
27 |
$0.00 |
| 90700 |
|
31 |
31 |
$0.00 |
| 90648 |
|
15 |
15 |
$0.00 |
| 90713 |
|
27 |
27 |
$0.00 |
| 90685 |
|
15 |
14 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
1,513 |
1,422 |
$0.00 |
| 90698 |
|
165 |
165 |
$0.00 |
| 90686 |
|
83 |
81 |
$0.00 |
| 90744 |
|
33 |
33 |
$0.00 |
| 97535 |
Self-care/home management training, each 15 minutes |
52 |
52 |
$0.00 |
| 90660 |
|
12 |
12 |
$0.00 |
| 90680 |
|
107 |
105 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
31 |
29 |
$0.00 |
| 90619 |
|
28 |
26 |
$0.00 |
| 90651 |
|
66 |
64 |
$0.00 |